ID   UT-7/Epo
AC   CVCL_5202
SY   UT-7/EPO; UT-7-EPO; UT7-Epo
DR   Cell_Model_Passport; SIDM01925
DR   Lonza; 169
DR   Wikidata; Q54992038
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8329702;
WW   http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7%2fEpo
CC   Population: Japanese.
CC   Characteristics: EPO dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2233 ! UT-7
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=8329702; DOI=10.1182/blood.V82.2.456.456;
RA   Komatsu N., Yamamoto M., Fujita H., Miwa A., Hatake K., Endo T.,
RA   Okano H., Katsube T., Fukumaki Y., Sassa S., Miura Y.;
RT   "Establishment and characterization of an erythropoietin-dependent
RT   subline, UT-7/Epo, derived from human leukemia cell line, UT-7.";
RL   Blood 82:456-464(1993).
//